跳至主要内容
临床试验/NCT01948596
NCT01948596已完成2 期

The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO) : Open Trial

Tokyo Medical University4 个研究点 分布在 2 个国家目标入组 13 人开始时间: 2013年10月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
13
试验地点
4
主要终点
total score of the Hamilton Rating Scale for Depression (HAMD)

研究概览

简要总结

The present study aims to examine the efficacy and safety of omega-3 polyunsaturated fatty acids for pregnant women with depressive symptoms.

详细描述

Maternal depression can have a significant harmful influence on both mothers and children. Considering the possibility of adverse effects of antidepressants and previous meta-analyses showing the positive effects of omega-3 polyunsaturated fatty acids (PUFAs) supplementation in reducing depressive symptoms, omega-3 PUFAs may provide a safe strategy. The investigators evaluate efficacy and safety of omega-3 PUFAs for pregnant women with depressive symptoms.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • pregnant women aged 20 years or older
  • between 12-24 weeks gestation
  • a Japanese conversational ability in Japan site or a Mandarin conversational ability in Taiwan site to understand the scope of the present trial and to provide written consent for study participation
  • planned to return to the hospital for checkup at 4-6 weeks after childbirth
  • an Edinburgh Postnatal Depression Scale (EPDS) score is 9 or more
  • to have good physical health judged by obstetricians.

排除标准

  • history and current suspicion of psychosis or bipolar I disorder or substance-related disorder or eating disorder or personality disorder
  • the item of EPDS concerning suicide ideation is 2 or more
  • other serious psychiatric symptoms such as self-harm behavior or in need of rapid psychiatric treatment
  • difficult to expect a normal birth (ex: fetal malformation etc.)
  • having a history of bleeding disorder such as von Willebrand's Disease
  • regular treatment with aspirin or warfarin within the last 3 months
  • a smoking habit of ≥40 cigarettes per day
  • regular treatment with ethyl icosapentate or regular consumption of omega-3 PUFA supplements within the last 3 months
  • a habit of eating fish ≥4 times per week.

结局指标

主要结局

total score of the Hamilton Rating Scale for Depression (HAMD)

时间窗: Twelve weeks

次要结局

  • IL-1 beta in plasma(twelve weeks, 4-6 weeks after childbirth)
  • major depressive disorder (MDD) as determined by the depression module of the Mini International Neuropsychiatric Interview (MINI)(Twelve weeks, 4-6 weeks after childbirth)
  • oxytocin in plasma(twelve weeks, 4-6 weeks after childbirth)
  • total score of the Beck Depression Inventory Ⅱ(BDI-Ⅱ)(Twelve weeks, 4-6 weeks after childbirth)
  • total score of HAMD(4-6 weeks after childbirth)
  • total scores on the Edinburgh Postnatal Depression Scale (EPDS)(Twelve weeks, 4-6 weeks after childbirth)
  • omega-3 fatty acids concentrations in erythrocytes(Tweve weeks, 4-6 weeks after childbirth)
  • TNF-alpha in plasma(twelve weeks, 4-6 weeks after childbirth)
  • phospholipase A2 in plasma(twelve weeks, 4-6 weeks after childbirth)
  • brain-derived neurotrophic factor (BDNF) in serum(Twelve weeks, 4-6 weeks after childbirth)
  • IF-6 in plasma(twelve weeks, 4-6 weeks after childbirth)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Daisuke Nishi

Assistant Professor

Tokyo Medical University

研究点 (4)

Loading locations...

相似试验